{"id":"hyperpolarized-xe129","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL4594411","moleculeType":"Small molecule","molecularWeight":"128.90"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"It works by exploiting the difference in magnetic properties between hyperpolarized xenon-129 and regular xenon-129, allowing for more detailed imaging of tissues and tumors. This can help doctors diagnose and monitor cancer more accurately.","oneSentence":"Hyperpolarized Xe129 is a magnetic resonance imaging (MRI) contrast agent that enhances the visibility of tumors and other lesions.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T03:50:41.547Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Diagnosis and monitoring of cancer"}]},"trialDetails":[{"nctId":"NCT07046910","phase":"PHASE2","title":"Developing Hyperpolarized Gas MRI Signatures to Detect and Manage Acute Cellular Rejection","status":"RECRUITING","sponsor":"University of Virginia","startDate":"2019-04-01","conditions":"Lung Transplant Rejection","enrollment":60},{"nctId":"NCT06856525","phase":"PHASE2, PHASE3","title":"Dissolved Phase HXe-129 MRI: A Novel Biomarker to Quantify Pulmonary Pathology","status":"RECRUITING","sponsor":"Y. Michael Shim, MD","startDate":"2024-12-19","conditions":"Electronic Cigarette Related Lung Damage","enrollment":80},{"nctId":"NCT02740868","phase":"PHASE2","title":"Xenon-129 and Inert Fluorinated Gas Lung MRI: Study of Healthy Volunteers and Participants With Pulmonary Disease","status":"RECRUITING","sponsor":"The Hospital for Sick Children","startDate":"2015-08","conditions":"Cystic Fibrosis, Asthma","enrollment":30},{"nctId":"NCT06909201","phase":"PHASE1","title":"Hyperpolarized Xenon-129 Magnetic Resonance Imaging in Lung Cancer Patients Receiving Radiation Therapy for Investigating Radiation-response and Toxicity","status":"SUSPENDED","sponsor":"M.D. Anderson Cancer Center","startDate":"2025-10-16","conditions":"Lung Cancer","enrollment":70},{"nctId":"NCT06038630","phase":"PHASE2","title":"129Xe MRI Cardiopulmonary","status":"RECRUITING","sponsor":"Bastiaan Driehuys","startDate":"2024-01-12","conditions":"Interstitial Lung Disease, Chronic Thromboembolic Pulmonary Hypertension, Acute Pulmonary Embolism","enrollment":125},{"nctId":"NCT04467957","phase":"PHASE4","title":"Non-contrast Lung Perfusion Mapping Applied for New Insights in Cystic Fibrosis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2020-11-15","conditions":"Cystic Fibrosis","enrollment":26},{"nctId":"NCT05302817","phase":"PHASE1","title":"Functional Lung Avoidance Radiation Therapy Using Hyperpolarized Xenon-129 MRI","status":"TERMINATED","sponsor":"Xemed LLC","startDate":"2023-03-17","conditions":"Carcinoma, Non-Small-Cell Lung","enrollment":9},{"nctId":"NCT05816616","phase":"","title":"Hyperpolarized Xenon Functional Lung Imaging in COPD Patients Undergoing Targeted Lung Denervation","status":"WITHDRAWN","sponsor":"Xemed LLC","startDate":"2025-09-01","conditions":"COPD","enrollment":""},{"nctId":"NCT06339593","phase":"EARLY_PHASE1","title":"Regional Monitoring of CF Lung Disease","status":"RECRUITING","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2024-01-05","conditions":"Cystic Fibrosis","enrollment":60},{"nctId":"NCT05914506","phase":"","title":"Hyperpolarized 129-Xenon MRI in Fibrosing Interstitial Lung Disease","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Aarhus","startDate":"2023-10-05","conditions":"Progressive Fibrosing Interstitial Lung Disease","enrollment":30},{"nctId":"NCT02220426","phase":"PHASE1","title":"Hyperpolarized Xenon-129 Magnetic Resonance Imaging and Spectroscopy of Brown Fat: Healthy Adult Volunteer Pilot Study","status":"TERMINATED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2015-09-01","conditions":"Obesity","enrollment":17},{"nctId":"NCT07139899","phase":"","title":"Downstream Effects of Airway Mucus Plugs on 129Xenon MRI in Severe Asthma","status":"RECRUITING","sponsor":"Bastiaan Driehuys","startDate":"2025-11-17","conditions":"Severe Asthma","enrollment":5},{"nctId":"NCT04941573","phase":"","title":"Assessment of Chronic Lung Allograft Dysfunction Using Single-breath & Multi-breath Hyperpolarized Xenon-129 MRI","status":"TERMINATED","sponsor":"Xemed LLC","startDate":"2021-01-19","conditions":"Lung Transplant Rejection","enrollment":45},{"nctId":"NCT05433961","phase":"PHASE1","title":"Functional and Structural Assessment of Endobronchial Valve Recipients Using Dynamic Hyperpolarized Xenon-129 MRI","status":"TERMINATED","sponsor":"Xemed LLC","startDate":"2023-10-20","conditions":"COPD","enrollment":27},{"nctId":"NCT05550662","phase":"PHASE2","title":"HP 129Xe MRI for Evaluation of CLAD in Lung Transplant Recipients","status":"TERMINATED","sponsor":"The Hospital for Sick Children","startDate":"2024-02-07","conditions":"Lung Transplant Rejection","enrollment":6},{"nctId":"NCT02195206","phase":"","title":"Hyperpolarized Xenon-129 Lung and/or Brain Magnetic Resonance Imaging: Healthy Adult Volunteer Pilot Study","status":"TERMINATED","sponsor":"The Hospital for Sick Children","startDate":"2014-07","conditions":"Healthy","enrollment":40},{"nctId":"NCT03909477","phase":"","title":"Longitudinal Study of Xenon-129 MRI Imaging Effects of Cannabis Smoking","status":"RECRUITING","sponsor":"Western University, Canada","startDate":"2022-06-01","conditions":"Cannabis Use, Cannabis Smoking, Marijuana Smoking","enrollment":200},{"nctId":"NCT04616313","phase":"","title":"Novel Pulmonary Imaging of Lung Structure and Function in E-cigarette Smokers","status":"RECRUITING","sponsor":"Western University, Canada","startDate":"2023-01-17","conditions":"E Cigarette Use","enrollment":150},{"nctId":"NCT04584671","phase":"","title":"Lung Structure-Function In Survivors of Mild and Severe COVID-19 Infection","status":"ACTIVE_NOT_RECRUITING","sponsor":"Western University, Canada","startDate":"2021-01-01","conditions":"Covid19","enrollment":100},{"nctId":"NCT06853145","phase":"EARLY_PHASE1","title":"Hyperpolarized Xenon-129 MRI in Idiopathic Pulmonary Fibrosis","status":"RECRUITING","sponsor":"University of Virginia","startDate":"2025-05-01","conditions":"Idiopathic Pulmonary Fibrosis","enrollment":6},{"nctId":"NCT04624490","phase":"PHASE1","title":"Hyperpolarized 129Xe MR Imaging of Lung Function in Healthy Volunteers and Subjects With Pulmonary Disease","status":"RECRUITING","sponsor":"Mario Castro, MD, MPH","startDate":"2020-11-02","conditions":"Asthma, COPD, Interstitial Lung Disease","enrollment":260},{"nctId":"NCT04659707","phase":"PHASE1","title":"Hyperpolarized 129Xe MRI of Survivors of COVID-19","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Kansas Medical Center","startDate":"2021-02-22","conditions":"Covid19","enrollment":20},{"nctId":"NCT05204355","phase":"","title":"MRI for Screening and Monitoring Scleroderma ILD","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Kansas Medical Center","startDate":"2022-05-01","conditions":"Scleroderma","enrollment":25},{"nctId":"NCT05766384","phase":"","title":"Hyperpolarized 129Xe MRI Lung Health Cohort","status":"RECRUITING","sponsor":"University of Kansas Medical Center","startDate":"2023-11-30","conditions":"Healthy","enrollment":260},{"nctId":"NCT05339386","phase":"","title":"Developing Hyperpolarized 129Xe MRI Biomarkers for Evaluation of Pulmonary Arterial Hypertension","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Kansas Medical Center","startDate":"2022-08-29","conditions":"Pulmonary Arterial Hypertension","enrollment":10},{"nctId":"NCT03002389","phase":"PHASE2","title":"Hyperpolarized Xenon-129 MRI: a New Multi-dimensional Biomarker to Determine Pulmonary Physiologic Responses to COPD Therapeutics","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Virginia","startDate":"2017-11-05","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":95},{"nctId":"NCT02638519","phase":"EARLY_PHASE1","title":"HP Xenon-129 fMRI of Healthy Volunteers and Participants With Alzheimer's Disease","status":"TERMINATED","sponsor":"Thunder Bay Regional Health Research Institute","startDate":"2016-06-27","conditions":"Alzheimer Disease","enrollment":51},{"nctId":"NCT02748798","phase":"EARLY_PHASE1","title":"Developing Optimal Parameters for Hyperpolarized Noble Gas and Inert Fluorinated Gas MRI of Lung Disorders","status":"TERMINATED","sponsor":"Thunder Bay Regional Health Research Institute","startDate":"2020-11-10","conditions":"Lung Transplant, Lung Resection, Lung Cancer","enrollment":10},{"nctId":"NCT03455686","phase":"NA","title":"Exploring the Utility of Hyperpolarized 129Xe MRI in Healthy Volunteers and Patients With Lung Disease","status":"RECRUITING","sponsor":"McMaster University","startDate":"2018-04-19","conditions":"Asthma, Chronic Obstructive Pulmonary Disease, Bronchiectasis","enrollment":60},{"nctId":"NCT06271408","phase":"PHASE1","title":"Comparison of Bronchodilator Response From Three Different Aerosol Delivery Methods in Patients With COPD Using Hyperpolarized Xe 129 MRI Ventilation Imaging","status":"UNKNOWN","sponsor":"Polarean, Inc.","startDate":"2024-02","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":6},{"nctId":"NCT06122922","phase":"PHASE2","title":"Xenon MRI in Stable Pulmonary Hypertension (Jupiter AUGEAN)","status":"WITHDRAWN","sponsor":"Bastiaan Driehuys","startDate":"2024-03-15","conditions":"Pulmonary Artery Hypertension","enrollment":""},{"nctId":"NCT03367312","phase":"PHASE2","title":"Assessing Response to Inhaled Prostacyclin With Hyperpolarized Xe MRI","status":"COMPLETED","sponsor":"Bastiaan Driehuys","startDate":"2018-03-29","conditions":"Pulmonary Vascular Disease","enrollment":11},{"nctId":"NCT05838703","phase":"PHASE2","title":"Tiotropium Handihaler vs. Tiotropium Respimat in COPD","status":"WITHDRAWN","sponsor":"Duke University","startDate":"2023-05-01","conditions":"Chronic Obstructive Pulmonary Disease (COPD)","enrollment":""},{"nctId":"NCT02723513","phase":"NA","title":"Bronchopulmonary Dysplasia: From Neonatal Chronic Lung Disease to Early Onset Adult COPD","status":"COMPLETED","sponsor":"Western University, Canada","startDate":"2016-04-01","conditions":"Bronchopulmonary Dysplasia, Preterm Birth","enrollment":3},{"nctId":"NCT03632369","phase":"","title":"Hyperpolarized Noble Gas MRI Detection of Radiation-Induced Lung Injury","status":"WITHDRAWN","sponsor":"Thunder Bay Regional Health Research Institute","startDate":"2016-12","conditions":"Radiation Induced Lung Injury, Non Small Cell Lung Cancer","enrollment":""},{"nctId":"NCT03884842","phase":"PHASE3","title":"Dupilumab on Airway Hyper-responsiveness and Ventilation Heterogeneity in Patients With Asthma.","status":"COMPLETED","sponsor":"McMaster University","startDate":"2019-07-01","conditions":"Asthma","enrollment":24},{"nctId":"NCT04677426","phase":"PHASE2","title":"129Xe Gas Exchange Imaging in IPF and cHP: A Reliability Study","status":"WITHDRAWN","sponsor":"University of Kansas Medical Center","startDate":"2022-05-01","conditions":"Idiopathic Pulmonary Fibrosis, Hypersensitivity Pneumonitis","enrollment":""},{"nctId":"NCT03078192","phase":"PHASE2","title":"Non-Invasive Diagnosis of Pulmonary Vascular Disease Using Inhaled 129Xe Magnetic Resonance Imaging","status":"COMPLETED","sponsor":"Bastiaan Driehuys","startDate":"2017-05-03","conditions":"Pulmonary Vascular Disease","enrollment":62},{"nctId":"NCT03482960","phase":"EARLY_PHASE1","title":"Comparison of 129Xe MRI With 19F MRI in CF Lung Disease","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2018-05-29","conditions":"Cystic Fibrosis","enrollment":11},{"nctId":"NCT04662658","phase":"PHASE1, PHASE2","title":"Hyperpolarized Xenon-129 MR Imaging of the Lung","status":"RECRUITING","sponsor":"University of Virginia","startDate":"2020-11-05","conditions":"E-Cig Use","enrollment":24},{"nctId":"NCT02826343","phase":"EARLY_PHASE1","title":"New Technology to Assess Treatment for Chronic Obstructive Pulmonary Disease (COPD)","status":"COMPLETED","sponsor":"University of Virginia","startDate":"2016-05-01","conditions":"Pulmonary Disease, Chronic Obstructive","enrollment":30},{"nctId":"NCT03331302","phase":"PHASE1, PHASE2","title":"Hyper Polarized Xenon-129 MRI vs Xenon-133 Scintigraphy","status":"RECRUITING","sponsor":"University of Virginia","startDate":"2018-09-01","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":30},{"nctId":"NCT04029636","phase":"","title":"Hyperpolarized 129Xe MRI for the Assessment of BOS With Late Onset LONIPC","status":"UNKNOWN","sponsor":"Hamilton Health Sciences Corporation","startDate":"2019-08","conditions":"Bronchiolitis Obliterans","enrollment":45}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["HP Xenon","129Xe","Xenon MRI","129 HXe MRI","Xenon, 129Xe, HP Xenon"],"phase":"phase_2","status":"active","brandName":"Hyperpolarized Xe129","genericName":"Hyperpolarized Xe129","companyName":"Mario Castro, MD, MPH","companyId":"mario-castro-md-mph","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Hyperpolarized Xe129 is a magnetic resonance imaging (MRI) contrast agent that enhances the visibility of tumors and other lesions. Used for Diagnosis and monitoring of cancer.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":3,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}